Various tumours, classically specified as either neuroendocrine or non-neuroendocrine,
contain high numbers of somatostatin receptors, which enable in vivo localization of the primary …

… spectral matching technique (van der Meer and Bakker, 1997). More recently a stochastic …
through combinations of key absorption features into areas in the VIS-SWIR spectrum wh…

Preliminary Communication Page 1 242 The observed rise in the average doppler frequency
shift was striking. We know that the angle of the ultrasound beam to the vessel in each …

Purpose There are few treatment options for patients with metastasized or inoperable endocrine
gastroenteropancreatic (GEP) tumors. Chemotherapy can be effective, but the response …

MATERIALS AND METhODS Sdn@ graphy with@ l-Tyr-3-octreotidehas several major
drawbacks as regards its metabolic behavior, its cumbersome preparationandtheshortphysicalhalf…

The somatostatin analogue [DOTA 0 ,Tyr 3 ]octreotate has a nine-fold higher affinity for the
somatostatin receptor subtype 2 as compared with [DOTA 0 ,Tyr 3 ]octreotide. Also, labelled …

Medical treatment and chemotherapy are seldom successful in achieving objective tumour
reduction in patients with metastatic neuroendocrine tumours. Treatment with the …

Fifty patients with somatostatin receptor-positive tumors were treated with multiple doses of [
111 In-diethylenetriamine pentaacetic acid 0 ]octreotide. Forty patients were evaluable after …

The kidneys are critical organs in peptide receptor radiation therapy (PRRT). Renal function
loss may become apparent many years after PRRT. We analyzed the time course of decline …

In preclinical studies in rats we evaluated biodistribution and therapeutic effects of different
somatostatin analogs, [ 111 In-DTPA]octreotide, [ 90 Y-DOTA, Tyr 3 ]octreotide and [ 177 Lu-…